News

RSV vaccine access expanded to some people in their 50s, according to CDC website
The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60.
MedPage Today on MSN23h
CDC Follows Advice of Ousted Vaccine Panel, Expands Access to RSV Shot
The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...
US CDC accepts ousted vaccine panel's recommendations for RSV, meningococcal shots
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...
US CDC accepts RSV recommendations made by former vaccine panel
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by an advisory panel in April on the ...
BioSpace8h
Kennedy Follows RSV Recommendations of ACIP Members He Fired
Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...
TwistedSifter on MSN3h
Research Shows Widespread RSV Vaccination Reduces Infant Hospitalizations
It is a mistake to claim that there is not widespread research into the effectiveness of vaccines, especially those given to ...
pharmaphorum20h
GSK gets EU okay for RSV shot in younger age group
GSK gets EU approval for its RSV vaccine Arexvy in a younger age group, a potential leg-up in a market tussle with Pfizer and Moderna ...
pharmaphorum1d
MSD eyes June verdict for paediatric RSV antibody
The FDA has started a review of MSD's respiratory syncytial virus (RSV) antibody clesrovimab, with a verdict due in the middle of next year. If approved by the 10th June action date, clesrovimab ...